fesoterodine fumarate

FDA Drug Profile — fesoterodine fumarate, Toviaz

fesoterodine fumarate is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand names including fesoterodine fumarate, Toviaz. Available dosage form: tablet, film coated, extended release.

Drug details

Generic Name
fesoterodine fumarate
Brand Names
fesoterodine fumarate, Toviaz
Application Number
ANDA204946
Sponsor
Zydus Pharmaceuticals USA Inc.
NDC Codes
6
Dosage Forms
TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients
FESOTERODINE FUMARATE

Indications and Usage

1 INDICATIONS AND USAGE Fesoterodine fumarate extended-release tablets are indicated for the treatment of: Overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. ( 1.1 ) 1.1 Adult Overactive Bladder Fesoterodine fumarate extended-release tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. Pediatric use information is approved for Pfizer Inc.'s TOVIAZ ® (fesoterodine fumarate) Extended-Release Tablets. However, due to Pfizer Inc.'s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.